MarketCap
Facebook
X
Telegram
Clearside Biomedical Langfristiger Schuldenstrom | CLSD
Langfristiger Schuldenstrom Jährlich Clearside Biomedical
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 375 K | 364 K | 349 K | 387 K | 373 K | 360 K | 556 K | 3.2 M | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.2 M | 349 K | 746 K |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
103 K | - | 5743.5 % | $ 69.7 M |  Canada |
 |
BioAtla
BCAB
|
1.43 M | $ 1.74 | 0.64 % | $ 102 M |  USA |
 |
Catalyst Pharmaceuticals
CPRX
|
437 K | - | - | $ 3.85 B | USA |
 |
UroGen Pharma Ltd.
URGN
|
481 K | $ 25.32 | -3.78 % | $ 1.22 B |  Israel |
 |
Catalyst Biosciences
CBIO
|
636 K | $ 13.91 | 1.9 % | $ 1.24 B | USA |
 |
ARCA biopharma
ABIO
|
619 K | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
75 K | - | 4.01 % | $ 150 M | Canada |
 |
ADiTx Therapeutics
ADTX
|
808 K | - | - | $ 374 | USA |
 |
Aeterna Zentaris
AEZS
|
215 K | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
181 K | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
554 K | - | 1.93 % | $ 17.4 M | USA |
 |
Aileron Therapeutics
ALRN
|
48 K | - | 10.36 % | $ 9.8 M | USA |
 |
AlloVir
ALVR
|
316 K | - | 4.14 % | $ 49.1 M | USA |
 |
Apellis Pharmaceuticals
APLS
|
7.09 M | - | - | $ 5.18 B | USA |
 |
Athira Pharma
ATHA
|
465 K | - | - | $ 269 M | USA |
 |
AVROBIO
AVRO
|
889 K | - | 1083.1 % | $ 745 M | USA |
 |
AstraZeneca PLC
AZN
|
382 M | - | - | $ 96.9 B |  Britain |
 |
Brainstorm Cell Therapeutics
BCLI
|
208 K | - | -2.5 % | $ 5.88 M | USA |
 |
BeiGene, Ltd.
BGNE
|
20.7 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
EyePoint Pharmaceuticals
EYPT
|
2.02 M | $ 0.39 | 9.06 % | $ 28.6 K | USA |
 |
Bio-Path Holdings
BPTH
|
83 K | - | - | $ 100 K | USA |
 |
Cara Therapeutics
CARA
|
116 K | - | -3.03 % | $ 260 M | USA |
 |
ChromaDex Corporation
CDXC
|
1 M | - | -0.88 % | $ 598 M | USA |
 |
Caladrius Biosciences
CLBS
|
137 K | - | -16.75 % | $ 25.8 M | USA |
 |
Diffusion Pharmaceuticals
DFFN
|
113 K | - | 11.68 % | $ 8.97 M | USA |
 |
Eloxx Pharmaceuticals
ELOX
|
4 K | - | -5.68 % | $ 8.28 M | USA |
 |
Enochian Biosciences
ENOB
|
294 K | - | - | $ 40.5 M | USA |
 |
Esperion Therapeutics
ESPR
|
2.1 M | - | - | $ 661 M | USA |
 |
Evofem Biosciences
EVFM
|
128 K | - | 7.55 % | $ 38.1 M | USA |
 |
Eyenovia
EYEN
|
512 K | - | 49.81 % | $ 13.2 M | USA |
 |
FibroGen
FGEN
|
12.6 M | - | - | $ 889 M | USA |
 |
Homology Medicines
FIXX
|
693 K | - | 0.77 % | $ 53.4 M | USA |
 |
Amicus Therapeutics
FOLD
|
8.74 M | - | - | $ 4.47 B | USA |
 |
Frequency Therapeutics
FREQ
|
2.67 M | - | - | $ 528 M | USA |
|
Galecto
GLTO
|
15 K | - | - | $ 762 M |  Danmark |
 |
GlycoMimetics
GLYC
|
435 K | - | 9357.83 % | $ 1.01 B | USA |
 |
Graybug Vision
GRAY
|
203 K | - | -11.23 % | $ 9.65 M | USA |
|
Galera Therapeutics
GRTX
|
133 K | - | -32.59 % | $ 7.61 M | USA |
 |
Happiness Biotech Group Limited
HAPP
|
155 K | - | 1.35 % | $ 17.8 M |  China |
 |
Novavax
NVAX
|
9.88 M | $ 10.15 | -6.8 % | $ 1.64 B | USA |
 |
Hepion Pharmaceuticals
HEPA
|
116 K | - | -18.79 % | $ 39.3 K | USA |
 |
Hoth Therapeutics
HOTH
|
5.68 K | - | - | $ 18.8 M | USA |
 |
IMARA
IMRA
|
399 K | - | 15.96 % | $ 663 M | USA |
 |
KalVista Pharmaceuticals
KALV
|
1.62 M | - | - | $ 1.45 B | Britain |
 |
KemPharm
KMPH
|
419 K | - | -0.34 % | $ 200 M | USA |
 |
Kezar Life Sciences
KZR
|
2.33 M | - | - | $ 53.3 M | USA |
 |
Lixte Biotechnology Holdings
LIXT
|
595 K | - | - | $ 63.4 M | USA |